Natalia Baran: Promising Results in a Challenging Patient Population with Locally Advanced Unresectable ESCC
Natalia Baran, Leading Attending, Assistant Professor at the University Clinic for Hematology, Insel Group, and Adjunct Assistant Professor at the University of South Dakota, Sanford School of Medicine, shared a post on LinkedIn about a paper she co-authored with Wenxue Ma, published in the World Journal of Clinical Oncology:
“Excited and grateful for the collaborative editorial work with Prof. Wenxue Ma, just published in World Journal of Clinical Oncology, analyzing the implications of induction chemoimmunotherapy followed by definitive radiotherapy or concurrent chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESCC).
This review highlights a recent study by Wei et al. demonstrating promising results in a challenging patient population with locally advanced unresectable disease.
While the results of the study are encouraging, we stress the need for further validation through prospective clinicaltrials and biomarker-based, immune response studies to refine patient selection and maximize therapeutic benefits.
This piece explores the implications of this research, its potential impact on clinical practice, and provides insights into future directions for advancing the ESCC treatment landscape.”
Title: Expanding horizons in esophageal squamous cell carcinoma: The promise of induction chemoimmunotherapy with radiotherapy
Authors: Wenxue Ma and Natalia Baran.
You can read the Full Article in the World Journal of Clinical Oncology.
More posts featuring Natalia Baran.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023